Jill Gicking McConnell is the Chief Financial Officer of Fortrea (Nasdaq: FTRE). She has served in this position since Fortrea’s launch as an independent company in July 2023 following its spinoff from Labcorp (NYSE: LH).
Georgina Strickland is Chief of Staff and Head of Strategy at Fortrea, leading the development of corporate strategy. She has served in this position since Fortrea’s launch as an independent company in July 2023.
Drayton Virkler is President and Chief Commercial Officer at Fortrea, focused on improving the probability of success of biopharmaceutical companies across the globe as they bring life-saving and life-enhancing products to the market.
David Cooper has served as Fortrea’s Chief Administrative Officer since May 2023, responsible for Human Resources, Procurement, Facilities and Corporate Communications.
Our endocrinology professionals leverage their extensive diabetes and lipid disorder experience to help you create streamlined solutions. Learn more here.
Fortrea's cutting-edge scientific and medical experts leverage global outreach to provide patient-centric clinical trials, astute counsel and enterprise-wide centers of excellence that yield true value in the form of transformative insights and applied market impact for dermatology studies.
Fortrea has over 30 years of worldwide experience in the late phase industry. We have deep institutional expertise across all therapeutic areas, established investigator relationships and broad real-world insights. Learn more here.
